GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro

Cited 8 time in scopus
Metadata Downloads
Title
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
Author(s)
K S Hong; J H Ahn; J G Jang; J H Lee; H N Kim; D Kim; Wonhwa Lee
Bibliographic Citation
Signal Transduction and Targeted Therapy, vol. 5, pp. 267-267
Publication Year
2020
ISSN
2095-9907
Publisher
Springer-Nature Pub Group
Full Text Link
http://dx.doi.org/10.1038/s41392-020-00391-5
Type
Article
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.